Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”
Keyword(s):
2019 ◽
Vol 143
(1)
◽
pp. 190-200.e20
◽
Keyword(s):